Organogenesis Holdings Inc.
ORGO
$2.48
$0.104.20%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -221.64% | 102.62% | 329.63% | 50.16% | -345.58% |
| Total Depreciation and Amortization | 103.17% | -0.14% | 6.47% | 6.74% | -3.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -117.74% | 429.43% | -35.20% | -34.37% | 174.13% |
| Change in Net Operating Assets | 261.50% | -46.14% | 21.62% | -84.04% | -205.55% |
| Cash from Operations | -46.41% | 1,180.29% | 109.37% | -64.90% | -282.27% |
| Capital Expenditure | 32.37% | -108.14% | 38.57% | -0.33% | -7.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 32.37% | -108.14% | 38.57% | -0.33% | -7.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,158.28% | -2.03% | -2.78% | -1.05% | 99.54% |
| Issuance of Common Stock | -- | -98.46% | -- | -100.00% | -97.65% |
| Repurchase of Common Stock | -3,406.90% | -4,250.00% | -- | 100.00% | 92.95% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -65.58% | 55.95% | -- | -- | -- |
| Cash from Financing | -320.32% | 52.89% | -3,444.10% | 85.99% | -106.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -107.45% | 419.97% | 74.56% | -43.65% | -162.14% |